Search

everythinglearnresearchcommunity

for

Search:↓

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

Simvastatin reduces inflammation and promotes hair regrowth in alopecia areata.

ILC1-like cells can independently cause alopecia areata.

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

Human dermal γδT-cells respond to stress in hair follicles, contributing to hair loss.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

BTNL2 helps protect hair follicles from immune attacks.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Targeting JAK-STAT1 can reduce inflammation and promote hair growth in conditions linked to EGFR deficiency.

Vitiligo and alopecia areata may have similar causes despite their differences.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Pantethine may boost the immune system's ability to fight sarcoma.

PINK1 is important for controlling gut immune responses linked to early Parkinson's disease.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Early regulatory T cells are crucial for normal skin pigmentation.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

Regulatory T-cells are important for healing and regenerating tissues in various organs by controlling immune responses and aiding stem cells.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

IL-15 is key for T cell function and could help improve treatments for immune-related diseases.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.